Dose-escalation Study of Oral Etoposide and Carboplatin in Patients with

Pacl i taxe l, Estramust ine Phosphate, and Carboplat in in Pat ients With Advanced Prostate Cancer

Kevin Kelly
Tracy Curley
Susan Slovin
Glenn Heller
John Mccaffrey
Dean Bajorin
Allison Ciolino
Kevin Regan Morton Schwartz
Eric J. Small
Lawrence Schwartz
Steve Larson
William Tong
Howard Scher

October 2016

Purpose: To determine the safety and activity of weekly paclitaxel in combination with estramustine ...

Pharmacokinetic Analysis of Carboplatin and Etoposide in a Small Cell Lung Cancer Patient Undergoing Hemodialysis

Takezawa, Ken
Okamoto, Isamu
Fukuoka, Masahiro
Nakagawa, Kazuhiko

September 2008

Cancer chemotherapy is not well established for patients on hemodialysis (HD). A 77-year-old man on ...

Cisplatin Plus Oral Etoposide in the Treatment of Patients with

Jpn J Clin Oncoi
Advanced Small
Cell Lung Cancer
Hitoshi Asamoto
Masaaki Kawahara
Fumiyuki Iwami
Mutsuo Kuba
Kiyoyuki Furuse
Tomohide Tamura
Nagahiro Saijo
Masanori Shimoyama
Japan Clinical
Oncology Group

October 2016

Background: Etoposide is a highly schedule-dependent drug. We investigated combination chemotherapy ...

Dose-escalation Study of Oral Etoposide and Carboplatin in Patients with Advanced Lung Cancer

Shinji Atagi
Kiyoyuki Furuse
Masaaki Kawahara
Nagahisa Kodama
Mitsumasa Ogawara
Kaoru Kubota
Kaoru Matsui
Yoko Kusunoki
Noriyuki Masuda
Minoru Takada
Masahiro Fukuoka

October 2016

A dose-escalation study of daily etoposide and carboplatin was carried out on 23 patients with advan...

A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer

Olver, I.
Stephenson, J.
Schulze, D.

January 2000

PurposeThis phase I study aimed to establish the dose for phase II trials of a dose-intense outpatie...

Evaluation of the therapeutic drug monitoring of carboplatin and pharmacokinetic-pharmacogenetic study of etoposide in phase II clinical trial of dose intensification in oncology

Moeung, Sotheara

October 2018

Le protocole TICE (Taxol, Ifosfamide, Carboplatine et Etoposide) représente le traitement standard d...

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Atrafi, Florence
Groen, Harry J. M.
Byers, Lauren A.
Garralda, Elena
Lolkema, Martijn P.
Sangha, Randeep S.
Viteri, Santiago
Chae, Young Kwang
Camidge, D. Ross
Gabrail, Nashat Y.
Hu, Beibei
Tian, Tian
Nuthalapati, Silpa
Hoening, Elizabeth
He, Lei
Komarnitsky, Philip
Calles, Antonio

January 2019

Purpose: This study examined safety, pharmacokinetics, and efficacy of veliparib, a PARP inhibitor, ...

Evaluation du suivi thérapeutique pharmacologique du carboplatine et étude pharmacocinétique-pharmacogénétique de l'étoposide dans le cadre d'un essai clinique de phase II d'intensification thérapeutique en cancérologie

Moeung, Sotheara

October 2018

The TI-CE protocol ((Taxol, Ifosfamide, Carboplatin and Etoposide) is the standard treatment of germ...

Summary

A. H. Calvert
D. R. Newell

September 2016

Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on dr...

A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

Karampeazis, A
Vamvakas, L.
Agelaki, Sofia
Kentepozidis, N
Papadimitraki, E
Gioulbasanis, I.
Vardakis, N
Ignatiadis, Michail
Mavroudis, Dimitris
Georgoulias, Vassilis

January 2006

To determine the maximum tolerated doses (MTDs) and the dose-limiting toxicities of a biweekly admin...

A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors.

Castello MA
Clerico A
Jenkner A
Dominici C

January 1990

Carboplatin was administered at 1,000 mg/m2/course in combination with etoposide at 300 mg/m2/course...

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

Ustun, C
Celebi, H
Uysal, A
Aydintug, S
Demirer, S
Akan, H
Koc, H
Demirer, T
Ilhan, O
Mandel, NM
Arat, M
Gunel, N

January 2000

The purpose of this study was to determine the maximum tolerated dose of carboplatin administered wi...

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer

Planting, André
Kho, Marcia
Burg, Maria
Goey, Hoo
Schellens, Jan
Bent, Martin
Gaast, Ate
Boer-Dennert, Maureen
Stoter, Gerrit
Verweij, Jaap

July 1997

textabstractAs a dose-response relationship has been suggested for cisplatin, it appeared attractive...

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

Banerjee, S.
Rustin, G.
Paul, J.
Williams, C.
Pledge, S.
Gabra, H.
Skailes, G.
Lamont, A.
Hindley, A.
Goss, G.
Gilby, E.
Hogg, M.
Harper, P.
Kipps, E.
Lewsley, L-A
Hall, M.
Vasey, P.
Kaye, S. B.

March 2013

Background: The aim of the study is to demonstrate that intrapatient dose escalation of carboplatin ...

Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancer

Olver, I.
Keefe, D.
Myers, M.

January 2005

The definitive version is available at www.blackwell-synergy.comAim : To develop a well-tolerated ou...

Pacl i taxe l, Estramust ine Phosphate, and Carboplat in in Pat ients With Advanced Prostate Cancer

Kevin Kelly
Tracy Curley
Susan Slovin
Glenn Heller
John Mccaffrey
Dean Bajorin
Allison Ciolino
Kevin Regan Morton Schwartz
Eric J. Small
Lawrence Schwartz
Steve Larson
William Tong
Howard Scher

October 2016

Purpose: To determine the safety and activity of weekly paclitaxel in combination with estramustine ...

Pharmacokinetic Analysis of Carboplatin and Etoposide in a Small Cell Lung Cancer Patient Undergoing Hemodialysis

Takezawa, Ken
Okamoto, Isamu
Fukuoka, Masahiro
Nakagawa, Kazuhiko

September 2008

Cancer chemotherapy is not well established for patients on hemodialysis (HD). A 77-year-old man on ...

Cisplatin Plus Oral Etoposide in the Treatment of Patients with

Jpn J Clin Oncoi
Advanced Small
Cell Lung Cancer
Hitoshi Asamoto
Masaaki Kawahara
Fumiyuki Iwami
Mutsuo Kuba
Kiyoyuki Furuse
Tomohide Tamura
Nagahiro Saijo
Masanori Shimoyama
Japan Clinical
Oncology Group

October 2016

Background: Etoposide is a highly schedule-dependent drug. We investigated combination chemotherapy ...

Dose-escalation Study of Oral Etoposide and Carboplatin in Patients with Advanced Lung Cancer

Shinji Atagi
Kiyoyuki Furuse
Masaaki Kawahara
Nagahisa Kodama
Mitsumasa Ogawara
Kaoru Kubota
Kaoru Matsui
Yoko Kusunoki
Noriyuki Masuda
Minoru Takada
Masahiro Fukuoka

October 2016

A dose-escalation study of daily etoposide and carboplatin was carried out on 23 patients with advan...

A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer

Olver, I.
Stephenson, J.
Schulze, D.

January 2000

PurposeThis phase I study aimed to establish the dose for phase II trials of a dose-intense outpatie...

Evaluation of the therapeutic drug monitoring of carboplatin and pharmacokinetic-pharmacogenetic study of etoposide in phase II clinical trial of dose intensification in oncology

Moeung, Sotheara

October 2018

Le protocole TICE (Taxol, Ifosfamide, Carboplatine et Etoposide) représente le traitement standard d...

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Atrafi, Florence
Groen, Harry J. M.
Byers, Lauren A.
Garralda, Elena
Lolkema, Martijn P.
Sangha, Randeep S.
Viteri, Santiago
Chae, Young Kwang
Camidge, D. Ross
Gabrail, Nashat Y.
Hu, Beibei
Tian, Tian
Nuthalapati, Silpa
Hoening, Elizabeth
He, Lei
Komarnitsky, Philip
Calles, Antonio

January 2019

Purpose: This study examined safety, pharmacokinetics, and efficacy of veliparib, a PARP inhibitor, ...

Evaluation du suivi thérapeutique pharmacologique du carboplatine et étude pharmacocinétique-pharmacogénétique de l'étoposide dans le cadre d'un essai clinique de phase II d'intensification thérapeutique en cancérologie

Moeung, Sotheara

October 2018

The TI-CE protocol ((Taxol, Ifosfamide, Carboplatin and Etoposide) is the standard treatment of germ...

Summary

A. H. Calvert
D. R. Newell

September 2016

Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on dr...

A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

Karampeazis, A
Vamvakas, L.
Agelaki, Sofia
Kentepozidis, N
Papadimitraki, E
Gioulbasanis, I.
Vardakis, N
Ignatiadis, Michail
Mavroudis, Dimitris
Georgoulias, Vassilis

January 2006

To determine the maximum tolerated doses (MTDs) and the dose-limiting toxicities of a biweekly admin...

A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors.

Castello MA
Clerico A
Jenkner A
Dominici C

January 1990

Carboplatin was administered at 1,000 mg/m2/course in combination with etoposide at 300 mg/m2/course...

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

Ustun, C
Celebi, H
Uysal, A
Aydintug, S
Demirer, S
Akan, H
Koc, H
Demirer, T
Ilhan, O
Mandel, NM
Arat, M
Gunel, N

January 2000

The purpose of this study was to determine the maximum tolerated dose of carboplatin administered wi...

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer

Planting, André
Kho, Marcia
Burg, Maria
Goey, Hoo
Schellens, Jan
Bent, Martin
Gaast, Ate
Boer-Dennert, Maureen
Stoter, Gerrit
Verweij, Jaap

July 1997

textabstractAs a dose-response relationship has been suggested for cisplatin, it appeared attractive...

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

Banerjee, S.
Rustin, G.
Paul, J.
Williams, C.
Pledge, S.
Gabra, H.
Skailes, G.
Lamont, A.
Hindley, A.
Goss, G.
Gilby, E.
Hogg, M.
Harper, P.
Kipps, E.
Lewsley, L-A
Hall, M.
Vasey, P.
Kaye, S. B.

March 2013

Background: The aim of the study is to demonstrate that intrapatient dose escalation of carboplatin ...

Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancer

Olver, I.
Keefe, D.
Myers, M.

January 2005

The definitive version is available at www.blackwell-synergy.comAim : To develop a well-tolerated ou...

Pacl i taxe l, Estramust ine Phosphate, and Carboplat in in Pat ients With Advanced Prostate Cancer

Kevin Kelly
Tracy Curley
Susan Slovin
Glenn Heller
John Mccaffrey
Dean Bajorin
Allison Ciolino
Kevin Regan Morton Schwartz
Eric J. Small
Lawrence Schwartz
Steve Larson
William Tong
Howard Scher

October 2016

Purpose: To determine the safety and activity of weekly paclitaxel in combination with estramustine ...

Pharmacokinetic Analysis of Carboplatin and Etoposide in a Small Cell Lung Cancer Patient Undergoing Hemodialysis

Takezawa, Ken
Okamoto, Isamu
Fukuoka, Masahiro
Nakagawa, Kazuhiko

September 2008

Cancer chemotherapy is not well established for patients on hemodialysis (HD). A 77-year-old man on ...

Cisplatin Plus Oral Etoposide in the Treatment of Patients with

Jpn J Clin Oncoi
Advanced Small
Cell Lung Cancer
Hitoshi Asamoto
Masaaki Kawahara
Fumiyuki Iwami
Mutsuo Kuba
Kiyoyuki Furuse
Tomohide Tamura
Nagahiro Saijo
Masanori Shimoyama
Japan Clinical
Oncology Group

October 2016

Background: Etoposide is a highly schedule-dependent drug. We investigated combination chemotherapy ...

Dose-escalation Study of Oral Etoposide and Carboplatin in Patients with

Abstract

Extracted data

Dose-escalation Study of Oral Etoposide and Carboplatin in Patients with

Abstract

Extracted data

Related items

Related items